Alzheimer's disease-like alterations in peripheral cells from presenilin-1 transgenic mice

被引:55
|
作者
Eckert, A
Schindowski, K
Leutner, S
Luckhaus, C
Touchet, N
Czech, C
Müller, WE
机构
[1] Univ Frankfurt, Dept Pharmacol, Bioctr, D-60439 Frankfurt, Germany
[2] Aventis Pharma, Res & Dev, F-94403 Vitry, France
关键词
Alzheimer's disease; presenilin-1; cell death; calcium; oxidative stress; lymphocytes; cytochrome c;
D O I
10.1006/nbdi.2000.0378
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Many cases of early-onset inherited Alzheimer's disease (AD) are caused by mutations in the presenilin-1 (PS1) gene. Expression of PS1 mutations in cell culture systems and in primary neurons from transgenic mice increases their vulnerability to cell death. Interestingly, enhanced vulnerability to cell death has also been demonstrated for peripheral lymphocytes from AD patients. We now report that lymphocytes from PS1 mutant transgenic mice show a similar hypersensitivity to cell death as do peripheral cells from AD patients and several cell culture systems expressing PS1 mutations. The cell death-enhancing action of mutant PS1 was associated with increased production of reactive oxygen species and altered calcium regulation, but not with changes of mitochondrial cytochrome c. Our study further emphasizes the pathogenic role of mutant PS1 and may provide the fundamental basis for new efforts to close the gap between studies using neuronal cell lines transfected with mutant PS1, neurons from transgenic animals, and peripheral cells from AD patients. (C) 2001 Academic Press.
引用
收藏
页码:331 / 342
页数:12
相关论文
共 50 条
  • [31] Myoclonus in genetic Alzheimer's disease due to presenilin-1 mutation
    Uccellini, Davide
    Canafoglia, Laura
    Franceschetti, Silvana
    Stabile, Andrea
    Catania, Marcella
    Tagliavini, Fabrizio
    Giaccone, Giorgio
    Di Fede, Giuseppe
    CLINICAL NEUROPHYSIOLOGY, 2023, 156 : 86 - 88
  • [32] Monogenic determinants of familial Alzheimer's disease: Presenilin-1 mutations
    Kovacs, DM
    Tanzi, RE
    CELLULAR AND MOLECULAR LIFE SCIENCES, 1998, 54 (09) : 902 - 909
  • [33] Presenilin-1 may mediate Taupathy in Sporadic Alzheimer's disease
    Zhu, C. Q.
    JOURNAL OF ALZHEIMERS DISEASE, 2002, 4 (01) : 54 - 55
  • [34] Increased Permeability of the Blood-Brain Barrier and Alzheimer's Disease-Like Alterations in Slit-2 Transgenic Mice
    Li, Jiang-chao
    Han, Lu
    Wen, Yin-xin
    Yang, Yong-xia
    Li, Shuai
    Li, Xue-song
    Zhao, Chang-jiang
    Wang, Ting-yu
    Chen, Hui
    Liu, Ying
    Qi, Cui-ling
    He, Xiao-dong
    Gu, Qu-liang
    Ye, Yu-xiang
    Zhang, Yu
    Huang, Ren
    Wu, Yu-e
    He, Rong-rong
    Kurihara, Hiroshi
    Song, Xiao-yu
    Cao, Liu
    Wang, Li-jing
    JOURNAL OF ALZHEIMERS DISEASE, 2015, 43 (02) : 535 - 548
  • [35] Presenilin-1 mutation Alzheimer's disease: A genetic epilepsy syndrome?
    Larner, A. J.
    EPILEPSY & BEHAVIOR, 2011, 21 (01) : 20 - 22
  • [36] Alzheimer's disease - Molecular consequences of presenilin-1 mutation - Reply
    Russo, C
    Schettini, G
    Saido, TC
    Hulette, C
    Lippa, C
    Lannfelt, L
    Ghetti, B
    Gambetti, P
    Tabaton, M
    Teller, JK
    NATURE, 2001, 411 (6838) : 655 - 656
  • [37] Transcriptional regulation of the presenilin-1 gene: implication in Alzheimer's disease
    Das, Hriday K.
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2008, 13 : 822 - 832
  • [38] Presenilin-1's second role in Alzheimer's
    不详
    CHEMICAL & ENGINEERING NEWS, 2003, 81 (36) : 24 - 24
  • [39] Novel 'inflammatory plaque' pathology in presenilin-1 Alzheimer's disease
    Shepherd, CE
    Gregory, GC
    Vickers, JC
    Halliday, GM
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2005, 31 (05) : 503 - 511
  • [40] Presenilin-1 protein expression in familial and sporadic Alzheimer's disease
    Levey, AI
    Heilman, CJ
    Lah, JJ
    Nash, NR
    Rees, HD
    Wakai, M
    Mirra, SS
    Rye, DB
    Nochlin, D
    Bird, TD
    Mufson, EJ
    ANNALS OF NEUROLOGY, 1997, 41 (06) : 742 - 753